Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Colorectal carcinoma: current problems and future perspectives

H J Schmoll1

  • 1Department of Hematology and Oncology, Hannover University Medical School, Germany.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|January 1, 1994
PubMed
Summary

Adjuvant chemotherapy and immunotherapy show comparable results for colorectal cancer treatment. Combining these strategies may offer improved outcomes for patients with resectable stages, warranting further investigation in clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO).

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Quality assurance in the treatment of colorectal cancer: the EURECCA initiative.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Area of Science:

  • Oncology
  • Surgical Oncology
  • Medical Oncology

Background:

  • Colorectal carcinoma serves as a model for solid tumor development and treatment strategies.
  • Current standards include adjuvant systemic 5-fluorouracil (5-FU)/levamisole for stage III colon cancer.
  • Adjuvant immunotherapy with monoclonal antibodies or tumor vaccines shows comparable efficacy to chemotherapy.

Purpose of the Study:

  • To evaluate adjuvant and neoadjuvant treatment strategies for resectable colorectal cancer.
  • To explore the combination of chemotherapy and immunotherapy for improved patient outcomes.
  • To investigate novel treatment approaches for rectal cancer, including neoadjuvant chemoradiation.

Main Methods:

  • Systemic 5-FU/levamisole and 5-FU/folinic acid chemotherapy regimens.

Related Experiment Videos

  • Short-term intraportal 5-FU infusion.
  • Adjuvant immunotherapy with 17-1A monoclonal antibody or autologous tumor vaccine.
  • Combined modality treatment with 5-FU/folinic acid and radiation therapy.

    • Main Results:

    • Adjuvant chemotherapy (5-FU/levamisole, 5-FU/folinic acid, intraportal 5-FU) improves disease-free and overall survival.
    • Adjuvant immunotherapy yields results comparable to adjuvant chemotherapy.
    • Ongoing studies investigate combinations of regional and systemic chemotherapy, and neoadjuvant chemoradiation for rectal cancer.

    Conclusions:

    • Combination of chemotherapy and immunotherapy holds significant promise for colorectal cancer treatment.
    • Neoadjuvant chemoradiation followed by surgery and adjuvant chemotherapy is a promising approach for locally advanced rectal cancer.
    • Future research should incorporate immunotherapy to further enhance survival benefits.